Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.

Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A; Australian Ovarian Cancer Study Group, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Ness RB, Edwards RP, Jensen A, Kjær SK, Høgdall E, Berchuck A, Cramer DW, Terry KL, Poole EM, Bandera EV, Paddock LE, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Wu AH, Pike MC, Webb PM.

Br J Cancer. 2017 Apr 25;116(9):1223-1228. doi: 10.1038/bjc.2017.68. Epub 2017 Mar 28.

2.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.

Nagle CM, Ibiebele TI, DeFazio A, Protani MM, Webb PM; Australian Ovarian Cancer Study Group.

Cancer Epidemiol. 2015 Apr;39(2):196-9. doi: 10.1016/j.canep.2014.12.010. Epub 2015 Feb 7.

PMID:
25666512
3.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjær SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N; Ovarian Cancer Association Consortium.

J Natl Cancer Inst. 2014 Feb;106(2):djt431. doi: 10.1093/jnci/djt431.

4.

Use of analgesic drugs and risk of ovarian cancer: results from a Danish case-control study.

Ammundsen HB, Faber MT, Jensen A, Høgdall E, Blaakaer J, Høgdall C, Kjaer SK.

Acta Obstet Gynecol Scand. 2012 Sep;91(9):1094-102. doi: 10.1111/j.1600-0412.2012.01472.x.

PMID:
22646488
5.

Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.

Baandrup L, Faber MT, Christensen J, Jensen A, Andersen KK, Friis S, Kjaer SK.

Acta Obstet Gynecol Scand. 2013 Mar;92(3):245-55. doi: 10.1111/aogs.12069. Epub 2013 Jan 22. Review.

PMID:
23240575
6.

Analgesic medication use and risk of epithelial ovarian cancer in African American women.

Peres LC, Camacho F, Abbott SE, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Crankshaw S, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry P, Wang F, Schildkraut JM.

Br J Cancer. 2016 Mar 29;114(7):819-25. doi: 10.1038/bjc.2016.39. Epub 2016 Feb 23.

7.

Medication use and risk of ovarian carcinoma: a prospective study.

Lacey JV Jr, Sherman ME, Hartge P, Schatzkin A, Schairer C.

Int J Cancer. 2004 Jan 10;108(2):281-6.

8.

Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.

Pinheiro SP, Tworoger SS, Cramer DW, Rosner BA, Hankinson SE.

Am J Epidemiol. 2009 Jun 1;169(11):1378-87. doi: 10.1093/aje/kwp062. Epub 2009 Apr 2.

9.

Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa Women's Health Study.

Vaughan LE, Prizment A, Blair CK, Thomas W, Anderson KE.

Cancer Causes Control. 2016 Nov;27(11):1395-1402. Epub 2016 Sep 27.

10.

Aspirin, other NSAIDs, and ovarian cancer risk (United States).

Fairfield KM, Hunter DJ, Fuchs CS, Colditz GA, Hankinson SE.

Cancer Causes Control. 2002 Aug;13(6):535-42.

PMID:
12195643
11.
12.

Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.

Merritt MA, Rice MS, Barnard ME, Hankinson SE, Matulonis UA, Poole EM, Tworoger SS.

Lancet Oncol. 2018 Aug;19(8):1107-1116. doi: 10.1016/S1470-2045(18)30373-5. Epub 2018 Jul 18.

PMID:
30029888
13.

Aspirin and NSAIDs: effects in breast and ovarian cancers.

Crew KD, Neugut AI.

Curr Opin Obstet Gynecol. 2006 Feb;18(1):71-5. Review.

PMID:
16493264
14.

Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.

Murphy MA, Trabert B, Yang HP, Park Y, Brinton LA, Hartge P, Sherman ME, Hollenbeck A, Wentzensen N.

Cancer Causes Control. 2012 Nov;23(11):1839-52. doi: 10.1007/s10552-012-0063-2. Epub 2012 Sep 13. Review.

15.

Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer.

Rahme E, Ghosn J, Dasgupta K, Rajan R, Hudson M.

BMC Cancer. 2005 Dec 12;5:159.

16.

Use of paracetamol, low-dose aspirin, or non-aspirin non-steroidal anti-inflammatory drugs and risk of ovarian borderline tumors in Denmark.

Hannibal CG, Dehlendorff C, Kjaer SK.

Gynecol Oncol. 2018 Dec;151(3):513-518. doi: 10.1016/j.ygyno.2018.09.022. Epub 2018 Sep 21.

PMID:
30249529
17.

A case-control study of analgesic use and ovarian cancer.

Rosenberg L, Palmer JR, Rao RS, Coogan PF, Strom BL, Zauber AG, Stolley PD, Shapiro S.

Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):933-7.

18.

Regular use of analgesic drugs and ovarian cancer risk.

Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H.

Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):903-6.

19.

Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.

Harris RE, Kasbari S, Farrar WB.

Oncol Rep. 1999 Jan-Feb;6(1):71-3.

PMID:
9864404
20.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.

Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB.

Epidemiology. 2012 Mar;23(2):311-9. doi: 10.1097/EDE.0b013e3182456ad3.

Supplemental Content

Support Center